0001970622-25-000017
SEC filingUSA Rare Earth reports no revenues; net loss widened to $91.0M due to non-cash fair value losses, offset by $75M PIPE financing.
USA Rare Earth reported no operating revenues for the three and six months ended June 30, 2025, consistent with the prior year as the company remains in pre-revenue development stage. Total operating expenses for Q2 2025 were $8.8 million, a 190% increase from $3.0 million in Q2 2024. For the six-month period, operating expenses rose 130% to $17.5 million from $7.7 million. The net loss for six months was $91.0 million compared to $29.4 million in the prior year, primarily driven by a non-cash loss of $74.4 million on fair value of financial instruments (including the day-one loss on the $75M PIPE and revaluation of warrant liabilities). SG&A expenses increased $9.3 million (240%) due to merger-related bonuses, legal fees, litigation settlement, equity-based compensation, and marketing costs. R&D increased $0.5 million (10%) for feasibility studies and employee costs. Interest and dividend income rose $0.8 million due to higher money market balances.
The company operates as a single segment focused on rare earth magnet production and mineral extraction. No segment-level revenue or profit data is disclosed as operations have not commenced. The Stillwater Facility (magnet manufacturing) and Round Top Project (mining) are both in development, with no material revenue or cash flow from either.
Management acknowledges substantial doubt about the company's ability to continue as a going concern for 12 months from issuance of the financial statements, despite $121.8 million in cash as of June 30, 2025. The company's current strategic plan requires additional capital for raw material inventory, equipment, and construction at Stillwater to achieve revenue targets. Near-term priorities include completing magnet production capabilities and feasibility studies. No formal guidance on revenue or margins is provided. The $75M PIPE closing in May 2025 provides liquidity, but the company remains dependent on external financing and warrant exercises (“$21.9 million received in Q2 2025") to fund operations. The emerging growth company status allows for reduced disclosure and extended transition period for new accounting standards.
As of June 30, 2025, USA Rare Earth holds $121.8 million in cash and cash equivalents, primarily from the Merger and $75M PIPE financing. However, the company reports an accumulated deficit of $180.5 million and negative stockholders' equity of $131.9 million. The balance sheet is burdened by $269.0 million in liability-classified financial instruments, including $169.0 million in warrant liabilities and $100.0 million in earnout liabilities, both measured at fair value. The company has substantial doubt about its ability to continue as a going concern within the next twelve months.
The company has no disclosed purchase commitments for supply or capacity. Lease obligations total $1.4 million, including $1.0 million in finance leases and $0.4 million in operating leases. The company has a $7.0 million Tax Increment Financing grant from the Stillwater Economic Development Authority, repayable if certain investment and employment conditions are not met. A litigation settlement on July 1, 2025, requires issuance of 159,000 shares and $150,000 cash. The company also has potential transaction bonuses of up to $1.5 million, not yet accrued.
The company has not conducted any share buybacks or paid common dividends. Preferred dividends are accrued in kind at 12% per annum. Capital expenditures for the six months ended June 30, 2025, totaled $6.3 million, primarily for equipment deposits and construction in progress for the Stillwater facility. Debt decreased by $0.8 million as the Hatch Note was converted to equity. No new debt was issued.
The company operates as a single reportable segment: the vertically integrated domestic rare earth magnet supply chain. No segment-level revenue or operating income is disclosed, as the company has not yet generated revenue. All operations are in the United States.
The company reported a net loss of $91.0 million for H1 2025, but operating cash flow was a negative $18.2 million, significantly less than the net loss due to large non-cash adjustments. The largest adjustment was a $74.4 million loss on fair value of financial instruments, reflecting changes in warrant and derivative valuations. Excluding that, cash burn would have been higher. Equity-based compensation added $1.3 million, and settlement of litigation through issuance of common shares added $1.7 million.
Working capital changes were a net use of cash: prepaid and other assets increased by $1.0 million, accounts payable decreased by $2.8 million, and accrued liabilities decreased by $1.4 million. These swings indicate timing differences in payments and may normalize in future periods.
Capital expenditures of $6.3 million represent significant cash outflows for plant construction and equipment, aligning with the company's growth phase. Free cash flow (not explicitly stated) would be -$24.5 million (CFO minus capex).
Financing activities provided $129.6 million, primarily from PIPE financing ($70.2 million), merger proceeds ($22.9 million), and warrant exercises ($22.0 million). These inflows offset the operating and investing cash needs and boosted cash balance to $121.8 million at period end.
The company's cash flow reflects a pre-revenue development stage with heavy reliance on external financing. Continued capex and operating losses may require additional capital raises.